Elevation Oncology Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	601	1,256	619	1,264	-	-
Market Cap Growth	-23.46%	102.78%	-51.02%	-	-	-
Enterprise Value	564	1,262	654	899	-	-
Last Close Price	1.24	2.92	1.44	2.94	-	-
PE Ratio	-	-	-	51.61	-	-
PS Ratio	0.88	2.77	0.91	1.29	-	-
PB Ratio	1.84	10.05	1.10	2.08	-	-
P/TBV Ratio	2.80	10.06	1.10	2.08	-	-
P/OCF Ratio	9.34	591.44	-	-	-	-
EV/Sales Ratio	0.83	2.79	0.96	0.92	-	-
EV/EBITDA Ratio	-	-	-	25.77	-	-
EV/EBIT Ratio	-	-	-	27.31	-	-
Debt / Equity Ratio	0.21	0.33	0.07	0.06	0.78	0.63
Debt / EBITDA Ratio	-	-	-	0.92	3.09	1.43
Asset Turnover	0.95	0.84	0.77	1.37	2.31	-
Inventory Turnover	10.87	10.48	9.20	13.68	36.61	-
Quick Ratio	0.68	0.65	3.62	2.08	1.26	0.96
Current Ratio	1.14	1.04	4.13	2.46	1.42	1.18
Return on Equity (ROE)	-87.61%	-127.56%	-7.68%	6.57%	22.11%	-
Return on Assets (ROA)	-32.27%	-51.48%	-4.31%	2.88%	6.19%	-
Return on Capital (ROIC)	-48.63%	-72.24%	-6.12%	4.62%	11.20%	-
Return on Capital Employed (ROCE)	-	-	-	5.10%	16.60%	19.00%
Earnings Yield	-62.50%	-35.00%	-7.28%	1.94%	-	-
FCF Yield	7.82%	-0.87%	-29.18%	-15.67%	-	-
Payout Ratio	-	-	-	57.16%	77.10%	-
Buyback Yield / Dilution	-2.84%	-	-32.10%	-350.90%	-44.38%	-
Total Shareholder Return	-	-	-32.10%	-350.90%	-44.38%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.